Clinical Trial Update: Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome [Phase 3]

View source ↗

Summary

This clinical trial update notes that APC-0101 is in Phase 3 testing for safety and efficacy in neonatal respiratory distress syndrome and is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Respiratory Distress Syndrome

Drugs mentioned

• APC-0101

Snippet

Sponsor: Aerogen Pharma Limited | Conditions: Respiratory Distress Syndrome, Pre-term Infants | Phase 3 | Status: RECRUITING